EyeGate files to initiate Ocular Bandage Gel pilot study

EyeGate Pharmaceuticals has filed a protocol with the FDA to initiate a pilot study of its Ocular Bandage Gel eye drop for the treatment of punctate epitheliopathies, the company announced in a press release.
The FDA will take 30 days to review the filing and then will allow the study to start or provide comments to be addressed, the release said.
“This is potentially a large opportunity, as OBG would be the only eye drop treatment available for the millions of patients in the U.S. with [punctate epitheliopathies] and tear (Read more...)

Full Story →